TriloDocs Ltd Joins Genactis Group
April 16, 2025 – Clinical Trials, Other, Pharmaceutical – Genactis Group, TriloDocs, artificial intelligence, clinical study reports, clinical trials, medical writing
16 March 2025 — London, UK — We’re excited to share some important news! TriloDocs has recently been acquired by Genactis: a global leader in healthcare research and technology. This marks a significant milestone for us here at TriloDocs and opens the door to a new chapter of innovation and growth. What remains unchanged is our dedication to delivering cutting-edge solutions and outstanding service. We aim for this transition to enhance our capabilities and strengthen our ability to provide support moving forward.
What’s coming next?
It’s business as usual: your point of contact, ongoing discussions and plans remain unchanged. With Genactis’ backing, we’re accelerating our product roadmap and expanding support resources. We’re also offering updated demonstration sessions to show what’s ahead and how we can align with your needs. Going forward, we’re embracing a user-centric strategy — actively involving clients like you in shaping our product roadmap. Your feedback will directly influence how we prioritise, design, and deliver features that bring measurable value to your teams.
Here’s what TriloDocs users can expect in the near future:
✔️ New User Interface – cleaner, faster, easier to navigate
✔️ API Connections – for seamless integration into your workflows
✔️ Improved Usability – intuitive, streamlined experience
✔️ New Features – based on real client use cases
✔️ More Document Types – matching the diversity of your content needs
If you’d like to schedule a demonstration and discuss what this could mean for your medical writing team, please feel free to reply to this email or request a demo here: https://trilodocs.com/register-interest.
About TriloDocs
TriloDocs is an AI tool that generates an initial draft of a Clinical Study Report (CSR). Pulling from all source documents, the draft report accurately reflects the input material (protocol, statistical analysis plan, and the data tables and figures), leaving the crafting of the messages to the medical writer and the clinical team.
- Output is a Word file in the Transcelerate template (adaptable on request)
- Methods are generated from protocol, amendments, and Statistical Analysis Plan
- Results are generated from the TLFs creating text and in-text tables for all key parameters
- Focus is on highlighting clinically relevant findings – identifying cutoffs and decision points for transparency and clarity.
Building on years of knowledge from expert medical writers and combining this with the latest AI technology, we created a tool that is easy to use and incredibly powerful. TriloDocs does what software does well – it quickly and consistently processes information and finds signals in data. Leaving the humans to do the part they do best – interpreting the results. Visit: https://trilodocs.com.
About Genactis
The healthcare landscape is dynamic, with new drug developments, guideline updates and health trends changing at a rapid pace. Brands face a complex environment with the need to stay agile and adapt to market changes quickly. Our experience allows us to guide brands through this complexity, providing creative and intelligent approaches that deliver accurate, actionable insights. We control all critical aspects of the research process, adjusting and setting priorities as needed, thanks to our in-house medical recruiters, researchers, analytics and programming teams. We can offer our clients in-house medical recruitment and access to our proprietary panel of >20,000 verified and opt-in respondents (HCPS, Payors, KOLs, Lab Managers and Pharmacists). We have offices in Germany and the UK, and an extensive network of fieldwork partners and moderators across the globe. Visit: www.genactis.com.
